June 11, 2021
Via: Medical NewsThe National Comprehensive Cancer Network (NCCN) today announced the publication of new guidance on COVID-19 vaccines for people with cancer, intended to clear up confusion for patients and caregivers. The new four-page patient guide is based on the latest expert […]
June 11, 2021
Via: PharmaphorumThat will hold back the biotech’s Covaxin shot by several months, and the delay put pressure on Ocugen’s share price, which fell more than 25% after the announcement. The Philadelphia-based company said it had taken the decision to go down […]
Manufacturing, Research and Development
June 8, 2021
Via: FiercePharmaAfter investigating America’s supply chains, including those for drugs and pharmaceutical ingredients, the Biden administration has revelations to share—and it’s proposing a sweeping strategy to boost domestic drug production. Under the plan, the White House is establishing a public-private partnership […]
Cell and Gene Therapy, Industry, News, Pharma
June 7, 2021
Via: Pharma TimesThis includes the company’s lead pre-clinical ADC candidate IKS03, a potentially ‘best-in-class’ CD19-targeted asset for B-cell cancers. Iksuda will use the funds to support the progression of IKS03 into first-in-human Phase I clinical trials, and will also be used to […]
June 4, 2021
Via: FiercePharmaMost people don’t normally think about the intricacies of the pharma supply chain, but the COVID-19 pandemic suddenly pushed the topic front and center. Now a new ad campaign from the Healthcare Distribution Alliance celebrates the critical work of healthcare […]
June 4, 2021
Via: Drugs.comAn initial 25 million doses of coronavirus vaccines will be sent out this month to a “wide range of countries” in Latin America, the Caribbean, Southeast Asia and Africa, along with the Palestinian territories, war-ravaged Gaza and the West Bank, […]
Manufacturing, Research and Development
May 25, 2021
Via: FiercePharmaDespite a flurry of uncertainty surrounding Biogen’s Alzheimer’s hopeful aducanumab, the company has forged ahead with its launch preparations ahead of a pending FDA decision. Now, its Swiss manufacturing facility is a step closer to eventually churning out doses—should the […]
Clinical Trials, Research and Development
May 13, 2021
Via: PharmaphorumThe new molecule – called DSP-0038 – is being developed by Japan’s Sumitomo Dainippon Pharma (DSP), which is now starting a phase 1 trial in the US as a treatment for psychosis associated with Alzheimer’s, and to see if it […]
April 29, 2021
Via: World Pharma NewsModerna, Inc. (Nasdaq: MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced it is making new funding commitments to increase supply at its owned and partnered manufacturing facilities, which it expects will increase global 2022 capacity […]
April 19, 2021
Via: FiercePharmaThe stomach cancer field is littered with immunotherapy shipwrecks, but one has now safely sailed past the regulatory finish line. Bristol Myers Squibb’s Opdivo, used in tandem with chemotherapy, won FDA approval for previously untreated gastric cancer, gastroesophageal junction cancer […]
April 14, 2021
Via: EPM MagazineThe sheer speed of developing and gaining regulatory approval for effective vaccines against Covid-19 has been unprecedented. Transporting them rapidly and safely from manufacturing sites to vaccination centres and doctors’ surgeries across the world is possibly the biggest challenge the […]
Biotech, FDA, Industry, Regulations
April 12, 2021
Via: BioSpaceAirway Therapeutics, Inc., a biopharmaceutical company developing a new class of biologics to break the cycle of injury and inflammation for patients with respiratory and inflammatory diseases, today announced the U.S. Food and Drug Administration (FDA) has accepted its Investigational […]
Copyright © 2021. All rights reserved
